Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2023 Jul 28;29(9):2376. doi: 10.1038/s41591-023-02511-4

Publisher Correction: Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

Jun Yin 1,#, Jingnan Yuan 2,3,4,#, Yunjin Li 2,4, Yong Fang 1, Ruoxi Wang 2, Heng Jiao 1, Han Tang 1, Shaoyuan Zhang 1, Siyun Lin 1, Feng Su 1, Jianmin Gu 1, Tian Jiang 1, Dong Lin 1, Zhiliang Huang 1,5, Chaoxiang Du 1,5, Kui Wu 2,3,4,, Lijie Tan 1,5,, Qing Zhou 2,3,4,✉,#
PMCID: PMC10504064  PMID: 37507607

Correction to: Nature Medicine 10.1038/s41591-023-02469-3. Published online 24 July 2023.

In the version of this article initially published, the Abstract was missing the ClinicalTrials.gov identifier, NCT04215471, which has now been inserted in the HTML and PDF versions of the article.

Contributor Information

Kui Wu, Email: wukui@genomics.cn.

Lijie Tan, Email: tan.lijie@zs-hospital.sh.cn.

Qing Zhou, Email: zhouqing2@genomics.cn.


Articles from Nature Medicine are provided here courtesy of Nature Publishing Group

RESOURCES